Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
The Malaysian medtech regulator has issued a new circular and a related draft guidance to facilitate the export of medical devices manufactured by original equipment manufacturers.
Australia has introduced new civil penalties and amended criminal offense provisions for breaches of its therapeutic product advertising rules. More reforms to the advertising regulations are expected soon.
China proposes to merge its top drug and device regulator into a new combined body and create a medical reimbursement agency in moves directed at strengthening regulatory oversight.
Indian laboratories that manufacturers employ to test their products will now need to be registered with health-care product regulator CDSCO.
India’s firebrand pharma pricing authority chief has been transferred out amid sharply polarized views on either side of the debate around his controversial stint.
A new FAQ document from India's health-care products regulator clarifies requirements relating to manufacturing licenses and other issues under the new medical device rules that came into effect on Jan. 1.
India has appointed a temporary head for its Central Drugs Standard Control Organization, after terminating GN Singh’s position.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.